Its now a few weeks since the initial post. Talks of doom and gloom & 'the end to the biotech boom' seem to have subsided. Surprise surprise..
Looking at the Nasdaq index moves since that post it looks pretty bullish to me.
(I'll leave interpretation to the reader)
Question now is how far will this tertiary trend run (projections target around 450) and what will the lag be before Aus bio PE's start playing catch up?..
In my view there are some real Bio bargins on the table here in Aus at this point.
Especially those looking at foreign denomiation revenues (such as RMD/COH/CDY/BKL although BKL is no longer a secret).
